Continuous Glucose Monitoring and Hospitalization Outcomes in Adults with Insulin-Treated Type 2 Diabetes and Complex Care Needs: A Population-Based Study.
In this population-based cohort of adults with insulin-treated T2D and CCN, CGM initiation was associated with fewer hospitalizations, shorter hospital stays, and lower hospitalization costs, supporting the integration of diabetes technology into chronic care strategies for highly vulnerable populations.
Abstract
Aim
Continuous glucose monitoring (CGM) improves glycemic outcomes in insulin-treated type 2 diabetes (T2D), but evidence in individuals with complex care needs (CCN) is limited. We evaluated the association between CGM initiation and hospitalization outcomes in a population-based cohort of adults with insulin-treated T2D and CCN.
Methods
We conducted a population-based quasi-experimental study including all eligible adults with insulin-treated T2D and CCN who initiated CGM through the Andalusian Public Health System. Rates of acute diabetes-related complications and cardiovascular admissions were compared before and after CGM initiation using Poisson regression models adjusted for person-time. Interrupted time-series analyses, length of stay (LOS), and hospitalization costs were also evaluated.
Results
Of 17,561 adults initiating CGM, 5281 met criteria for CCN and were included (mean age 79 years; 55.1% aged ≥ 80 years). Acute diabetes-related hospitalization rates decreased from 144.27 to 41.04 per 10,000 person-years (rate ratio [RR] 0.28, 95% CI 0.19-0.42), and cardiovascular admission rates decreased from 387.25 to 251.96 per 10,000 person-years (RR 0.65, 95% CI 0.54-0.78). Interrupted time-series analyses showed post-intervention hospitalization rates consistently below counterfactual estimates. Mean LOS decreased by 3.68 days (95% CI -5.26 to -2.10; P < 0.001), and hospitalization costs decreased by USD657.39 per patient-year.
Conclusion
In this population-based cohort of adults with insulin-treated T2D and CCN, CGM initiation was associated with fewer hospitalizations, shorter hospital stays, and lower hospitalization costs, supporting the integration of diabetes technology into chronic care strategies for highly vulnerable populations.
BACKGROUND
Although continuous glucose monitoring (CGM) is well established for insulin-treated diabetes, its utility in non-insulin-treated type 2 diabetes (T2D) remains less studied.
OBJECTIVE
To evaluate the short-term clinical and economic outcomes following personal use of CGM in patients with T2D.
METHODS
Thi...
S. Gadd, Connor W. Willis, Ishfaq Rashid et al.· Journal of Managed Care & Sp...· 0 citations
BACKGROUND
The effectiveness of continuous glucose monitoring (CGM) in adults with type 2 diabetes (T2D) not receiving intensive insulin therapy remains incompletely established, particularly regarding glycemic metrics beyond glycated hemoglobin (HbA1c).
METHODS
We conducted a systematic review and meta-analysis of r...
A. A. Al Hayek, Wael M. Alzahrani, Haifa F. Alotaibi et al.· Journal of Diabetes Science...· 0 citations
Older adults aged ≥ 75 years with type 2 diabetes (T2D) experience high healthcare utilization, yet evidence on treatment patterns and outcomes in this age group is limited. To assess associations between glycemic control, kidney function, and hospitalization among individuals aged ≥ 75 years with T2D. Individuals aged...
Bertin Magamba, J. M. Jonasson, Louise Pettersson et al.· BMC Geriatrics· 0 citations
OBJECTIVES
While technology improves glycemic control, its psychological impact in resource-limited settings is less explored. This study evaluated the impact of continuous glucose monitoring (CGM) on diabetes distress and glycemic outcomes in adults with type 1 diabetes (T1D) within a public healthcare system.
METHO...
Nathalia Costa Monteiro, Laís Prado Smith Lima, J. P. A. Freitas et al.· Canadian Journal of Diabetes· 0 citations
Purpose
The long-term impact of continuous glucose monitoring (CGM) initiation on glycemic trajectories in children and adolescents with type 1 diabetes (T1D) remains unclear. We assessed 5-year glycated hemoglobin (HbA1c) trajectories according to CGM initiation timing in Korean children and adolescents with T1D.
Me...
Jun-Ha Dong, H. Kim, Jaehyun Kim· Annals of Pediatric Endocrin...· 0 citations
In patients with new-onset T2D, early statin initiation is associated with worse short-term glycemic improvement and a greater need for escalating glucose-lowering therapy; however, it is also associated with a substantial reduction in the long-term MACE risk.
Ying Ran, Li-Li Jiang, Jing Ran et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.